Amneal – Recall of lorazepam oral concentrate
August 14, 2017 – Amneal announced a consumer-level recall of thirteen lots of lorazepam oral concentrate 2 mg/mL due to a defect in the dropper markings. Lorazepam oral concentrate is packaged with a dosing dropper supplied to Amneal by a third party.
Download PDF
